These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3516792)

  • 1. Effects of ephedrine and atenolol on the development of obesity and diabetes in ob/ob mice.
    Bailey CJ; Thornburn CC; Flatt PR
    Gen Pharmacol; 1986; 17(2):243-6. PubMed ID: 3516792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactive C-peptide in spontaneous syndromes of obesity and diabetes in mice.
    Flatt PR; Bailey CJ; Hampton SM; Swanston-Flatt SK; Marks V
    Horm Metab Res; 1987 Jan; 19(1):1-5. PubMed ID: 3549500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the antiobesity agent sibutramine in obese-diabetic ob/ob mice.
    Day C; Bailey CJ
    Int J Obes Relat Metab Disord; 1998 Jul; 22(7):619-23. PubMed ID: 9705019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased responsiveness to glucoregulatory effect of opiates in obese-diabetic ob/ob mice.
    Bailey CJ; Flatt PR
    Diabetologia; 1987 Jan; 30(1):33-7. PubMed ID: 3032718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two novel glucagon receptor antagonists prove effective therapeutic agents in high-fat-fed and obese diabetic mice.
    O'Harte FP; Franklin ZJ; Irwin N
    Diabetes Obes Metab; 2014 Dec; 16(12):1214-22. PubMed ID: 25060150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of adrenal glands in the development of abnormal glucose and insulin homeostasis in genetically obese (ob/ob) mice.
    Bailey CJ; Day C; Bray GA; Lipson LG; Flatt PR
    Horm Metab Res; 1986 Jun; 18(6):357-60. PubMed ID: 3525360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihyperglycaemic effect of saccharin in diabetic ob/ob mice.
    Bailey CJ; Day C; Knapper JM; Turner SL; Flatt PR
    Br J Pharmacol; 1997 Jan; 120(1):74-8. PubMed ID: 9117102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob/ob mice.
    Irwin N; Montgomery IA; Moffett RC; Flatt PR
    Biochem Pharmacol; 2013 Jan; 85(1):81-91. PubMed ID: 23085436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice.
    Lee EY; Kim YW; Oh H; Choi CS; Ahn JH; Lee BW; Kang ES; Cha BS; Lee HC
    Metabolism; 2014 Jun; 63(6):793-9. PubMed ID: 24684824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component.
    Attele AS; Zhou YP; Xie JT; Wu JA; Zhang L; Dey L; Pugh W; Rue PA; Polonsky KS; Yuan CS
    Diabetes; 2002 Jun; 51(6):1851-8. PubMed ID: 12031973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Food restriction normalizes somatic growth and diabetes in adrenalectomized ob/ob mice.
    Dubuc PU; Carlisle HJ
    Am J Physiol; 1988 Nov; 255(5 Pt 2):R787-93. PubMed ID: 3056042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term restricted insulin production in obese-hyperglycemic (genotype ob/ob) mice.
    Boozer CN; Mayer J
    Diabetologia; 1976 May; 12(2):181-7. PubMed ID: 131728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term administration of PACAP receptor antagonist, PACAP(6-27), impairs glucose tolerance and insulin sensitivity in obese diabetic ob/ob mice.
    Green BD; Irwin N; Cassidy RS; Gault VA; Flatt PR
    Peptides; 2006 Sep; 27(9):2343-9. PubMed ID: 16730098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of exercise and food restriction on obesity and diabetes in young ob/ob mice.
    Dubuc PU; Cahn PJ; Willis P
    Int J Obes; 1984; 8(3):271-8. PubMed ID: 6378818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenoceptor-mediated control of glucose homeostasis in obese hyperglycaemic (ob/ob) mice.
    Bailey CJ; Flatt PR
    Diabetes Res; 1990 Jun; 14(2):87-91. PubMed ID: 1966872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically obese C57BL/6 ob/ob mice respond normally to sympathomimetic compounds.
    Wilson S; Arch JR; Thurlby PL
    Life Sci; 1984 Sep; 35(12):1301-9. PubMed ID: 6482654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice.
    Irwin N; McClean PL; O'Harte FP; Gault VA; Harriott P; Flatt PR
    Diabetologia; 2007 Jul; 50(7):1532-40. PubMed ID: 17486314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCO-792, an enteropeptidase inhibitor, improves disease status of diabetes and obesity in mice.
    Yashiro H; Hamagami K; Hiyoshi H; Sugama J; Tsuchimori K; Yamaguchi F; Moritoh Y; Sasaki M; Maekawa T; Yamada Y; Watanabe M
    Diabetes Obes Metab; 2019 Oct; 21(10):2228-2239. PubMed ID: 31144422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary components and plasma insulin responses to fasting and refeeding in genetically obese hyperglycaemic (ob/ob) mice.
    Flatt PR; Bailey CJ
    Br J Nutr; 1984 May; 51(3):403-13. PubMed ID: 6372856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats.
    Chang AY; Wyse BM; Gilchrist BJ; Peterson T; Diani AR
    Diabetes; 1983 Sep; 32(9):830-8. PubMed ID: 6354790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.